Clinical trials for genome editing of the human germline – adding, removing, or replacing DNA base pairs in gametes or early embryos – could be permitted in the future, but only for serious conditions under stringent oversight, says a new report.
from Top Health News – ScienceDaily http://bit.ly/2lhBrkk
from Tumblr http://bit.ly/2kI1T3y
No comments:
Post a Comment